Hematopoietic Stem Cell Transplant Associated Thrombotic Microangiopathy (HSCT-TMA)
1 clinical trials · Condition
◉ Watch Hematopoietic Stem Cell Transplant Associated Thrombotic Microangiopathy (HSCT-TMA)
| Record | Firm | Date |
|---|---|---|
| Single Patient Expanded Access Treatment Plan For The Investigational Product Narsoplimab (NCT04247906) | Omeros Corporation |
Track Hematopoietic Stem Cell Transplant Associated Thrombotic Microangiopathy (HSCT-TMA) automatically
Every clearance here is in the API, with alerts when new ones post.